news
Two therapeutic targets identified for lung cancer
Salk scientists discover a pair of enzymes that drive non-small-cell lung cancer by promoting inflammation which could inform the development of new therapies.
List view / Grid view
non-small cell lung cancer
news
First in vitro lung cancer test launched
A new in vitro lung cancer diagnostic test has been launched by Roche Diagnostics to provide improved detection of cancer.
news
PKCδ enzyme linked to therapy resistance in lung cancer
The enzyme protein kinase C delta (PKCδ) found in NSCLC tumors prevents tyrosine kinase inhibitors (TKIs) from forestalling cancer...
news
Nanoparticles shown to be effective in treating NSCLC
Non-small cell lung cancer Nanoparticles pass the next stage of development in preclinical tests...
news
Elimination of c-Raf kinase induces regression of advanced lung tumours
A study has shown how the elimination of the c-Raf kinase by genetic manipulation causes the regression of Kras oncogene-driven advanced lung tumours...
news
Blood tumour markers warn against the progression of lung cancer
Cancers can secrete complex molecules into the blood, researchers have now begun to further define their potential...
news
Novel immuno-oncology treatment for patients with advanced solid tumours
An experimental immuno-oncology treatment will move into early phase clinical trials for patients with advanced solid tumours...
news
Power of radiomics to improve precision medicine
Data mining of medical images with radiomics offers clinicians a way to characterise lung tumours and improve precision medicine...
news
Imfinzi wins breakthrough therapy designation
AstraZeneca and MedImmune, have today announced that the US Food and Drug Administration has granted breakthrough therapy designation for Imfinzi for the treatment of patients with locally-advanced, unresectable non-small cell lung cancer...
